Filing metadata

Accession number
0001209191-21-020163
Form type
Form 3
Filer
Chemomab Therapeutics Ltd.
CIK
CIK 1534248
Filed
Mar 12, 2021
Reporting period
Apr 23, 2020
Description
Initial ownership

Explore SEC Filings Hub